Here, we analyzed the role of the novel inhibitory receptor Ig-like transcript 2 (ILT2, also termed LIR-1, LILRB1) in the regulation of NK cells in CLL. Here, LILRB1 is linked to B-cell chronic lymphocytic leukemia.